icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
March 4-7, 2019
 		Back grey_arrow_rt.gif
 
 
 
ACTIVITY OF ECD4-IG AGAINST CCR5 ANTAGONIST-RESISTANT HIV-1
 
 
  Reported by Jules Levin
CROI 2019 March 4-7 Seattle

0313191

0313192

0313193

0313194

0313195

0313196

0313197

0313198

0313199

03131910

03131911

This work was supported in part by the grant from the National Institutes of Health/National Institute of Allergy and InfectiousDiseases (R37AI055357 ). Thanks the ACTG A5211 protocol team for providing the HIVDiseases (R37AI055357 ). Thanks the ACTG A5211 protocol team for providing the HIV-1 Env-genes of MCV-susceptible and -resistant viruses from a phase 2 trial of VCV.